Connect with us
Prague Gaming & TECH Summit 2024

Artificial Intelligence

Digital Diabetes Management Market Size to Touch USD 39,900 Billion By 2030

Published

on

LOS ANGELES, Jan. 18, 2023 (GLOBE NEWSWIRE) — The Global Digital Diabetes Management Market Size accounted for USD 6.5 Billion in 2021 and is estimated to garner a market size of USD 39.9 Billion by 2030 rising at a CAGR of 22.4% from 2022 to 2030. 

Digital Diabetes Management Market Overview

Why diabetes in on the rise?

Diabetes is a chronic metabolic disorder characterized by high blood sugar levels due to defects in insulin secretion, insulin action, or both. The exact cause of diabetes is not fully understood, but it is known to be a combination of genetic and environmental factors. The prevalence of diabetes has been on the rise in recent years due to a number of factors including increased obesity rates, a sedentary lifestyle, and an ageing population. Additionally, there is growing evidence to suggest that environmental toxins, such as certain pesticides and industrial chemicals, may contribute to the development of diabetes. The increase in the number of people with diabetes has also been linked to changes in diet and food systems, with a shift towards a diet high in processed foods and added sugars.

The Digital Diabetes Management Market is a rapidly growing industry that utilizes technology to aid in the management and treatment of diabetes. The market is highly technical in nature, as it involves advanced software and algorithms for analyzing data and integration of various medical devices such as continuous glucose monitoring systems, insulin pumps, and mobile health (mHealth) applications. These tools allow for real-time monitoring and tracking of glucose levels, insulin dosing, and other important health metrics, as well as remote communication with healthcare providers. The development of artificial intelligence and machine learning capabilities is also expected to play a key role in the future of this market, with the potential for personalized treatment plans and real-time monitoring of diabetes. Additionally, the incorporation of blockchain technology in the digital diabetes management market is also expected to increase data security and privacy for patients.

Request For Free Sample Report @ https://www.acumenresearchandconsulting.com/request-sample/2457

Digital Diabetes Management Market Report Coverage:

Market Digital Diabetes Management Market
Digital Diabetes Management Market Size 2021 USD 6.5 Billion
Digital Diabetes Management Market Forecast 2030 USD 39.9 Billion
Digital Diabetes Management Market CAGR During 2022 – 2030 22.4%  
Digital Diabetes Management Market Analysis Period 2018 – 2030
Digital Diabetes Management Market Base Year 2021  
Digital Diabetes Management Market Forecast Data 2022 – 2030
Segments Covered By Product, By Type, And By Geography
Digital Diabetes Management Market Regional Scope North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Key Companies Profiled Medtronic, B. Braun, Dexcom, Abbott Laboratories, Roche Diagnostics, Insulet Corporation, Tandem Diabetes Care, Ascensia Diabetes Care, LifeScan, Tidepool, AgaMatrix, Glooko Inc., and DarioHealth.
Report Coverage Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

Digital Diabetes Management Market Research Report Highlights and Statistics

  • The global Digital Diabetes management market size in 2021 stood at USD 6,500 Million and is set to reach USD 39,900 Million by 2030, growing at a CAGR of 22.4%
  • The increasing prevalence of diabetes and the growing adoption of digital health solutions are the major drivers for the growth of the market.
  • The mobile health (mHealth) segment is forecasted to lead the market, due to the increasing adoption of smartphones and the availability of mobile apps for diabetes management.
  • North American digital diabetes management market share is predicted to be the largest, due to the presence of a large patient population and the high adoption of digital health solutions in the region.
  • Key players in the market include Medtronic, Roche, Abbott, Glooko, and Dexcom.
  • The market is also witnessing a significant increase in the number of start-ups, with a focus on developing innovative solutions for diabetes management, such as continuous glucose monitoring devices and insulin pumps.
  • There has been a rise in diabetes cases in countries like India and China due to changing lifestyle and growing consumption of junk food leading to high obesity rates and adopting a sedentary lifestyle.
  • The use of big data analytics and artificial intelligence in diabetes management is expected to provide new opportunities for the growth of the market in the future.

Trends in the Digital Diabetes Management Market

Rising number diabetic patients and ageing population: The increasing prevalence of diabetes and the rising number geriatric population are expected to drive the growth of the market, as more people seek digital solutions to manage their condition.

Growing use of wearable devices: The increasing adoption of wearable devices for diabetes management, such as continuous glucose monitoring devices, is expected to drive the growth of the market.

Increasing adoption of mobile health (mHealth) solutions: The growing popularity of smartphones and the availability of mobile apps for diabetes management are expected to drive the growth of the mHealth segment in the market.

Increasing focus on remote monitoring and telemedicine: Remote monitoring is convenient as it can monitor patient data without the need for the patient to be physically present.

The emergence of blockchain technology in the market: Blockchain technology can help to ensure data security and privacy in diabetes management and can be an opportunity for growth in the market.

Other trends include the high number of smartphone adoption, rising healthcare costs and government initiatives to promote digital health solutions

Digital Diabetes Management Market Dynamics

Advancements in artificial intelligence and machine learning: The integration of artificial intelligence and machine learning in diabetes management is expected to provide new opportunities for personalized treatment plans and real-time monitoring of diabetes.

Rising awareness about digital health solutions in emerging economies: The increasing awareness about digital health solutions in emerging economies is expected to drive the growth of the market in these regions.

Increase in partnerships and collaborations between technology companies and healthcare providers.

Increasing investment in R&D: Many companies are investing in R&D to develop more advanced technologies for diabetes management, which is expected to drive the growth of the market.

The increasing use of big data analytics: The use of big data analytics in diabetes management is expected to provide new opportunities for the growth of the market in the future.

Other factors include rising healthcare expenditure and increasing disposable income in developing economies, growing emphasis and education about preventive healthcare and diabetes management and lastly incentives for providers to adopt digital health solutions.

Growth Hampering Factors

  • High Cost: Digital diabetes management tools can be quite expensive for some people who can find them to be unaffordable. This can limit market growth as it is not accessible to all.
  • Lack of awareness and education: A lot of people with diabetes are old, it can be difficult for them to properly understand how to use the digital diabetes solutions effectively.
  • Can be difficult to integrate with existing healthcare systems making it difficult for healthcare providers to access and use the data from these tools.
  • Privacy and security concerns: People can be skeptical to use digital diabetes management tools due to concerns about privacy and security of their personal health information.
  • Lack of patient engagement and adherence to digital diabetes management tools.

Check the detailed table of contents of the report @

https://www.acumenresearchandconsulting.com/table-of-content/digital-diabetes-management-market

Market Segmentation

The Digital Diabetes Management Market can be segmented based on:

Product:

  • Continuous Glucose Monitoring (CGM) systems
  • insulin pumps
  • Diabetes Management Software.

End-user:

Hospitals

  • Clinics
  • Homecare settings.

Application:

  • Type 1 diabetes
  • Type 2 diabetes
  • Gestational diabetes.

Age groups:

  • Adults
  • Children
  • Geriatrics.

Technology:

  • Wearable devices
  • Mobile Applications
  • Cloud-Based Solutions

Distribution channels

  • Direct-to-consumer
  • E-commerce
  • Retail pharmacies

Digital Diabetes Management Market Overview by Region

The Digital Diabetes Management Market can vary significantly by region. In North America, the digital diabetes market is highly developed and is driven by a high prevalence of diabetes and a strong healthcare infrastructure. Many of the major players in the market are based in North America, and the region is home to some of the most advanced digital diabetes management products and services.

In Europe, the market is also well-established, but with a different focus on the use of wearable technology and mobile applications. In this region, the digital diabetes management market share is driven by the increasing adoption of digital technologies in healthcare and the growing demand for remote monitoring and telemedicine services.

In Asia-Pacific, the digital diabetes management market is still in its nascent stage, but it is expected to grow the fastest in the coming years. This region has a large population of people with diabetes, and a growing awareness of digital diabetes management solutions is driving the market’s growth. In addition, a growing focus on preventative healthcare and increasing disposable incomes are also contributing to the market’s growth.

For regions like Latin America and Middle East and Africa, the market is still in the early stages of development, but it is expected to grow at a good pace in the coming years. This region has a high burden of diabetes, and the increasing adoption of digital technologies in healthcare is driving the market’s growth.

Buy this premium research report –

https://www.acumenresearchandconsulting.com/buy-now/0/2457

Digital Diabetes Management Market Key Players

Medtronic, Abbott, Dexcom, Roche, Siemens, Sanofi, Omron, Tandem, Novo Nordisk, Insulet Corporation, Livongo, DarioHealth, mySugr, MedAngel, Prodigy Diabetes Care, Glucovation, Senseonics, WellDoc, Cellnovo, Glucovation, MIM Software and Glooko.

Browse More Research Topic on Healthcare Sector Related Reports:

The Global Electrical Impedance Tomography Market Size gathered USD 4.1 Billion in 2021 and is set to garner a market size of USD 8.9 Billion by 2030 growing at a CAGR of 9.2% from 2022 to 2030.

The Global Orthostatic Hypotension Market Size gathered USD 715.2 Million in 2021 and is set to garner a market size of USD 1,422.9 Million by 2030 growing at a CAGR of 8.1% from 2022 to 2030.

The Global Capnography Devices Market Size accounted for USD 513 Million in 2021 and is estimated to achieve a market size of USD 1,134 Million By 2030 growing at a CAGR of 9.3% from 2022 to 2030.

About Acumen Research and Consulting:

Acumen Research and Consulting is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact-based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

For Latest Update Follow Us on Twitter , Instagram and LinkedIn

Contact Us:

Mr. Richard Johnson

Acumen Research and Consulting

USA: +13474743864

India: +918983225533

E-mail: [email protected]

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

XtalPi Unveils XtalGazer: A Comprehensive AI-Driven Polymorph Selection Platform

Published

on

xtalpi-unveils-xtalgazer:-a-comprehensive-ai-driven-polymorph-selection-platform

CAMBRIDGE, Mass., March 28, 2024 /PRNewswire/ — XtalPi Inc., a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced today the launch of its proprietary comprehensive solid form discovery and selection platform, XtalGazer. This advanced platform aims to significantly improve the polymorph selection process for the pharmaceutical industry by integrating AI- and automation-powered experimental and computational approaches.

XtalGazer provides a total solution for delivering high-quality polymorph screening and selection methods to expedite drug development and mitigate risks. It represents a paradigm shift in solid-state research, moving from the traditional trial-and-error approach to a data-driven, design-led methodology. The platform provides an expansive suite of foundational tools to accelerate polymorph discovery, characterization, and selection process, empowering pharmaceutical companies to conduct thorough research with less active pharmaceutical ingredient (API) in shorter development cycles.
A key component of XtalGazer is XtalCSP, a crystal structure prediction platform to perform global searches of crystal structures for target molecules and the other optional components in the corresponding searching space, offering a deep insight into possible stable forms. Furthermore, crystallization strategy recommendations will provide AI-backed experimental design to help avoid human bias. XtalGazer also utilizes MicroED to rapidly elucidate crystal structures from powder samples, reducing the need for growing single crystals.
XtalPi’s launch of XtalGazer marks another significant step in the company’s ongoing exploration of solid-state research. From crystal structure prediction platforms being one of the first products to launch at XtalPi, to today’s comprehensive polymorph selection platform, XtalPi will keep fulfilling its promise to solving challenging problems in this space. XtalPi will continue to deliver faster, more accurate, and more comprehensive approaches to building an ecosystem for the R&D process in solid-state, pre-formulation and crystallization.
For more information about XtalPi, please visit www.xtalpi.com.
About XtalPi:
XtalPi is an innovative technology company powered by artificial intelligence (AI) and robotics. Founded in 2015 on the MIT campus, XtalPi is dedicated to driving intelligent and digital transformation in the life science and new materials industries. With tightly interwoven quantum physics, AI, cloud computing, and large-scale clusters of robotic workstations, XtalPi offers a range of technology solutions, services, and products to accelerate and empower innovation for biopharmaceutical and new materials companies worldwide.
Media Contact: Vivienne [email protected]
Logo – https://mma.prnewswire.com/media/632519/XtalPi_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/xtalpi-unveils-xtalgazer-a-comprehensive-ai-driven-polymorph-selection-platform-302102794.html

Continue Reading

Artificial Intelligence

ICIS and Base Oil News Announce Partnership to Enhance Market Insights

Published

on

icis-and-base-oil-news-announce-partnership-to-enhance-market-insights

LONDON, March 28, 2024 /PRNewswire/ — ICIS, a global source of commodity intelligence, is pleased to announce a strategic partnership with Base Oil News, a premier news outlet founded by industry expert Iain Pocock that provides in-depth coverage of the base oils and lubricants market. This collaboration marks a significant milestone in the dissemination and exchange of critical market data and insights.

With more than two decades of journalism experience at Bloomberg, Reuters, and Argus Media, Iain Pocock brings unparalleled expertise to this partnership. His deep understanding of illiquid energy markets makes him a credible and influential figure in the industry. Since November 2023, Iain has been working closely with ICIS to share and exchange valuable data and insights, enhancing the services both platforms offer to the base oils and lubricants market.
Through the collaboration, Iain integrates ICIS’ extensive content and data resources in Base Oil News market coverage. In return, he contributes market insights to ICIS News, including expert and exclusive analysis of supply and demand dynamics, price margins, and other critical market drivers. This exchange ensures that subscribers of both ICIS and Base Oil News have access to the most comprehensive, timely, and accurate market information, empowering them to make informed decisions.
“It’s a very exciting partnership – where we leverage each other’s strengths and provide actionable insights to our customers,” said Iain Pocock, Founder of Base Oil News. “The market is the winner.”
“As ICIS is already the world’s most trusted pricing benchmark for base oils, this collaboration with Iain Pocock and Base Oil News provides an even stronger and deeper service to our customers,” said Stephen Burns, Editorial Director at ICIS. “Iain’s expertise and extensive industry connections are invaluable, and we have established a fruitful partnership that benefits the market at large.”
For the latest insights from Iain Pocock on ICIS News, visit ICIS News.  
About ICIS
ICIS – Independent Commodity Intelligence Services – helps businesses through seamlessly delivering data and analytics, across the chemical, fertilizer and energy markets. A trusted source and benchmark for price information and insight across key commodities markets worldwide. Our independent, transparent market intelligence informs thousands of quality decisions every day, taking the pressure out of negotiations and giving customers space for more innovative thinking, through published datasets including price assessments, price forecasts, supply and demand fundamentals and more.
Over 150 years of shaping the world by connecting markets to optimise the world’s valuable resources. With a global team of more than 600 experts, ICIS has employees based in London, New York, Houston, Karlsruhe, Milan, Mumbai, Singapore, Guangzhou, Beijing, Shanghai, Dubai, Sao Paulo, Seoul, Tokyo and Perth.
ICIS is part of RELX, a FTSE15 company with a market cap of £64bn and an employee base of over 30,000 experts across 40 countries.
About RELX
RELX is a global provider of information and analytics for professional and business customers across industries. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs approximately 30,000 people of whom almost half are in North America. RELX PLC is a London listed holding company which owns 52.9% of RELX Group. RELX NV is an Amsterdam listed holding company which owns 47.1% of RELX Group. The shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX and RENX. Total market capitalisation is approximately £64bn | €75bn | $81bn.
Logo: https://mma.prnewswire.com/media/619935/4277787/ICIS_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/icis-and-base-oil-news-announce-partnership-to-enhance-market-insights-302102782.html

Continue Reading

Artificial Intelligence

Trianz Welcomes Israel Abraham as Vice President of Services for Extrica.ai – The Data to AI Platform

Published

on

trianz-welcomes-israel-abraham-as-vice-president-of-services-for-extrica.ai-–-the-data-to-ai-platform

SANTA CLARA, Calif., March 28, 2024 /PRNewswire/ — Digital transformation technology & services company Trianz is pleased to announce the appointment of Israel Abraham as Vice President of Extrica Platform Services.

Trianz has embarked on a transformative journey, redefining its value proposition with an ‘IP Led’ model, with a commitment to deliver the fastest time to value, lowest human dependence, and highest ROI. Central to this approach are our hyper-automated platforms, Concierto.Cloud, Extrica.AI, and Pulse, driving industry-leading transformations in cloud, data and analytics, AI, and the digital workplace.
Israel Abraham is a very well-known pioneer and industry leader in AI, data management, and analytics systems, with over three decades of experience. He joins as the services leader for Extrica- the Trianz Data to AI platform, which productizes data, provides data a face and purpose, and accelerates time to insights and AI by 50% or more. In the role of Extrica Services leader, Israel will lead the shaping, visioning, and delivery of Extrica.ai based enterprise wide datamesh, BI, and AI solutions for customers worldwide.
“We are thrilled to welcome Israel Abraham to the Trianz family,” said Sri Manchala, CEO of Trianz and author of Crossing the Digital Faultline. “He is a leader in modernization as well as conceptualization of data platforms anew. Israel’s prior background in the industry with financial services and insurance giants underscores our commitment to securing top-tier talent that brings real-world experiences and needs to our technology platforms. As we continue to broaden our footprint in the digital transformation space, Israel’s visionary leadership and practical experience will serve as the cornerstone in accelerating insights and AI to deliver transformative value to our clients.”
Having played pivotal roles in highly reputed and large organizations such as Liberty Mutual Insurance, MassMutual, Safeco, and CNA Insurance, Israel has garnered recognition as a seasoned leader in big data and AI cloud implementations. His accolades include the prestigious 2014 Ventana Research IT Innovation Award, the 2009 Informatica MDM Innovation Award, and three filed Data Engineering patents in the last four years.
“Trianz has been at the forefront of digital innovation, and Extrica.ai is a paradigm shifting data to AI platform that completely changes how analytics and AI are delivered- much faster, taking business ahead of change. I am excited to scale the adoption of the Extrica platform, which has attracted attention from giants across the industry and hyperscalers,” said Israel Abraham. “I look forward to engaging with customers, bringing my own experiences, and collaborating with the talented team at Trianz to further enhance the capabilities of the Extrica Platform Services to transform data & AI strategies, execution, and outcomes for customers.”
About Trianz
Trianz is a leading-edge technology platforms and services company that accelerates digital transformations at Fortune 100 and emerging companies worldwide in data & analytics, digital experiences, cloud infrastructure, and security. Our ‘IP Led Transformations’ approach, informed by insights from a recent global study spanning 20+ industries and 5000+ companies, addresses challenges posed by the rapid pace of AI-driven transformation, digital talent scarcity, and economic uncertainty. Our IP and platforms, including Concierto, Extrica, and Pulse, revolutionize cloud adoption, data analytics, and AI insights, empowering organizations to navigate the complexities of digital transformation seamlessly.
Founded in California and with an organization of over 2,000 associates across the United States and India, Trianz is a Premier Partner of AWS, consistently rated #1 by clients for value delivery over the past five years. Trianz has been ranked as one of the best Consulting Firms by Forbes and has been certified as a Great Place to Work for three years in a row. To learn more about Trianz, email [email protected] or visit www.trianz.com.
Watch Trianz CEO Sri Manchala’s insightful interview with Bloomberg on Partner | Crossing The Digital Faultline & Leading Towards Transformative Success – YouTube and delve deeper into his book Crossing the Digital Faultline at Crossing the Digital Faultline | Trianz.
Trianz Media [email protected] +1-408-387-5800
Logo: https://mma.prnewswire.com/media/626944/1199800/Trianz_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/trianz-welcomes-israel-abraham-as-vice-president-of-services-for-extricaai–the-data-to-ai-platform-302102589.html

Continue Reading
Advertisement

Latest News

Trending